Amanote Research
Register
Sign In
P3.01-46 Prognostic Utility of Advanced Lung Cancer Inflammation Index (ALI) in Thoracic Malignancies: A Meta-Analysis
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1606
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
H. Elosta
S. Jafri
Publisher
Elsevier BV
Related search
P3.01-36 Prognostic Factors in Elderly Patients With Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.01-70 Meta-Analysis of Metformin in Combination With Platinum Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Prognostic Value of Plasma Fibrinogen in Lung Cancer Patients: A Meta-Analysis
Journal of Cancer
Oncology
Prognostic Value of microRNAs in Lung Cancer: A Systematic Review and Meta‑analysis
Molecular and Clinical Oncology
Cancer Research
Oncology
Prognostic Role of MicroRNA-181a/b in Hematological Malignancies: A Meta-Analysis
PLoS ONE
Multidisciplinary
Pump Operations in Locally Advanced Thoracic Malignancies
Acta medica Lituanica
Peripheral CD8+ T Cell Proliferation Is Prognostic for Patients With Advanced Thoracic Malignancies
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Homeobox Protein CDX2 as a Prognostic Biomarker in Solid Malignancies: A Meta-Analysis
Oncotarget
Oncology
Prognostic Value of ALDH1 and Nestin in Advanced Cancer: A Systematic Meta-Analysis With Trial Sequential Analysis
Therapeutic Advances in Medical Oncology
Oncology
